Study Stopped
Because of the difficulties of participant enrollment.
A Randomized, Prospective, Multicenter Study for the Role of Primary Tumor Resection in Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastasis
1 other identifier
interventional
52
1 country
12
Brief Summary
Short description for lay public, include brief statement of the study hypothesis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable colorectal-cancer
Started Sep 2013
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 31, 2013
CompletedFirst Posted
Study publicly available on registry
November 7, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedAugust 14, 2018
August 1, 2018
2.2 years
October 31, 2013
August 12, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of the overall survival between patients who underwent primary tumor resection and patients who received chemotherapy without primary tumor resection
Comparison of the overall survival between patients who underwent primary tumor resection followed by chemotherapy and patients who received chemotherapy without primary tumor resection in stage IV colorectal cancer patients with unresectable metastasis.
2 years after allocation
Secondary Outcomes (1)
Analysis of primary tumor related complications in the chemotherapy group and postoperative complications in the primary tumor resection followed by the chemotherapy group.
2 years after allocation
Other Outcomes (1)
To compare the quality of life between the two groups using the Korean version of EORTC QLQ (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire)-C30.
2 years after allocation
Study Arms (2)
Chemotherapy first without primary tumor resection
EXPERIMENTALPatients will receive chemotherapy first without primary tumor resection.
Primary tumor resection followed by chemotherapy
ACTIVE COMPARATORPatients will receive primary tumor resection followed by chemotherapy.
Interventions
primary tumor resection (PTR) using open or laparoscopy or robotic surgery
Eligibility Criteria
You may qualify if:
- Age : between 20 and 90 years old
- Histologically confirmed adenocarcinoma of the colon or the upper rectum
- Patients with resectable primary colon or upper rectal cancer and unresectable metastatic lesions.
- Patients with no primary cancer related symptoms.
- ECOG performance status of 0 - 2
- Appropriate organ functions (hepatic transaminases - less than 5 times the normal range; bilirubin - less than 2 times the normal range; creatinine serum - less than 1.5 times the normal range; thrombocyte - more than 100,000/µl; neutrophil - more than 1,500/µl)
- ASA score of \< 3
- An informed consent form has been signed by the patient.
You may not qualify if:
- The patient received adjuvant chemotherapy within the past 6 months.
- The patient received chemotherapy for metastatic colon cancer.
- The patient was planning to have curative surgery for the metastatic lesions.
- The primary cancer is unresectable.
- Patients with peritoneal carcinomatosis.
- Patients with mid and low rectal cancer (\< 10cm)
- Patients with primary tumor related complications such as intestinal obstruction, intractable bleeding, and perforation, that needs to be treated.
- ASA score of \> 4
- The patient has chronic hepatitis or cirrhosis. An asymptomatic HBV or HCV carrier can participate.
- Patients with an active infection, which need antibiotic therapy, during the randomization period.
- Pregnant or breastfeeding women
- Patients who were enrolled in another clinical trial during the time of enrollment (within the 28 day randomization period).
- Patients with another different malignant tumor during the past 5 years. Patients with treated non-melanoma skin cancer or cervical cancer can be enrolled in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (12)
University Sacred Heart Hospital
Anyang-si, Gyeonggi-do, South Korea
National Cancer Center
Ilsan, Gyeonggi-do, South Korea
Gachon University, Gil Hospital
Incheon, Gyeonggi-do, South Korea
Seoul National University, Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Yeongnam University Hospital
Daegu, Gyeongsang-do, South Korea
Wonkwang University Hospital
Iksan, Jeollabukdo, South Korea
Chonnam National University Hospital
Gwangju, Jeonlla Nam-do, South Korea
Kyungpook National University Hospital
Daegu, South Korea
Department of Surgery, Yonsei University College of Medicine
Seoul, 120-752, South Korea
Asan Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Yonsei University, Gangnam Severance Hospital
Seoul, South Korea
Related Publications (1)
Kim CW, Baek JH, Choi GS, Yu CS, Kang SB, Park WC, Lee BH, Kim HR, Oh JH, Kim JH, Jeong SY, Ahn JB, Baik SH. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: Study protocol for a randomized controlled trial. Trials. 2016 Jan 19;17:34. doi: 10.1186/s13063-016-1164-0.
PMID: 26782254DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2013
First Posted
November 7, 2013
Study Start
September 1, 2013
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
August 14, 2018
Record last verified: 2018-08